Drug-labels.com

Riva-Simvastatin (Laboratoire Riva, PM 00083947): Uses, Side Effects and Dosage

Status:
Prescription (Rx) Facts
Strength:
5 mg, 10 mg, 20 mg, 40 mg, 80 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Riva-Simvastatin (Laboratoire Riva, PM 00083947)

What is RIVA-SIMVASTATIN used for?

RIVA-SIMVASTATIN is used in adults and children (10 to less than 18 years of age). It is used in combination with a change in diet, to:

  • lower the levels of cholesterol and fatty substances called triglycerides in the blood; and
  • reduce blockages in the arteries.

In adults, RIVA-SIMVASTATIN can reduce the chance of experiencing health risks associated with Coronary Heart Disease (CHD) such as heart attack, stroke, or death.

How does RIVA-SIMVASTATIN work?

Simvastatin belongs to a class of medicines known as “statins”, more specifically called HMG-CoA reductase inhibitors. Statins block an enzyme called HMG-CoA reductase from being made in your liver, which is involved in the production of cholesterol in your body. RIVA-SIMVASTATIN is used along with a change in diet, to help control the amount of cholesterol in your blood. Medicines like this one are prescribed along with, and not as a substitute for, a special diet and other measures.

What are the ingredients in RIVA-SIMVASTATIN?

Medicinal ingredient: Simvastatin

Non-medicinal ingredients: Ascorbic acid, butyl hydroxyl anisole, citric acid, hydroxypropyl cellulose, hypromellose, isopropyl alcohol, lactose monohydrate, magnesium stearate, microcrystalline cellulose, starch, talc, and titanium dioxide.

Additionally 5 mg Tablets contain Iron oxide yellow, 10 mg & 20 mg tablets contain Iron oxide yellow & Iron oxide red and 40 mg & 80 mg tablets contain Iron oxide red.

RIVA-SIMVASTATIN comes in the following dosage forms:

Tablets: 5 mg, 10 mg, 20 mg, 40 mg and 80 mg.

Do not use RIVA-SIMVASTATIN if:

  • you are allergic to simvastatin or any non-medicinal ingredient in the RIVA-SIMVASTATIN formulation.
  • you are pregnant, think you may be pregnant, or intend to become pregnant; if you become pregnant, stop taking RIVA-SIMVASTATIN immediately and talk to your healthcare professional.
  • you are breastfeeding or intend to breastfeed.
  • you have active liver disease.
  • you are taking any of the following medicines: o certain antifungal medicines (itraconazole, ketoconazole, posaconazole, or voriconazole),

    • certain medicines used to treat HIV (nelfinavir, ritonavir, or saquinavir),
    • certain medicines used to treat hepatitis C virus (boceprevir or telaprevir),
    • certain antibiotics (erythromycin, clarithromycin, or telithromycin),
    • medicines containing cobicistat,
    • nefazodone, used to treat depression,
    • gemfibrozil, used for lowering cholesterol,
    • cyclosporine, used to prevent organ transplant rejection,
    • danazol, used to treat endometriosis or fibrocystic breast disease.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take RIVA-SIMVASTATIN. Talk about any health conditions or problems you may have, including if you:

  • have diabetes or are at risk of having diabetes
  • have thyroid problems
  • regularly drink three or more alcoholic drinks daily
  • had any past problems with the muscles (pain, tenderness), after using medicines such as atorvastatin, fluvastatin, lovastatin, pravastatin or rosuvastatin
  • do excessive physical exercise
  • have kidney or liver problems
  • have undergone surgery or other tissue injury or if you have a planned surgery
  • are taking any other cholesterol lowering medication such as fibrates (fenofibrate), niacin or ezetimibe
  • are Asian
  • are 65 years of age or older
  • feel weak or frail
  • have or have had myasthenia gravis (a disease causing general muscle weakness including the eye muscles and in some cases, muscles used for breathing) as statins
  • may lead to occurrence of myasthenia or aggravate the condition.

Other warnings you should know about:

Pregnancy: RIVA-SIMVASTATIN should not be taken during pregnancy as it may harm your unborn baby. If you are a woman who could become pregnant, your healthcare professional will ask you to use a highly effective birth control method while taking RIVA-SIMVASTATIN. If you discover you are pregnant while taking RIVA-SIMVASTATIN, stop taking the medicine and contact your healthcare professional right away.

Muscle disorders (myopathy or rhabdomyolysis): RIVA-SIMVASTATIN increases your risk of developing a severe muscle disorder. If you experience any unexplained muscle pain, tenderness or weakness, especially with a fever, tell your healthcare professional right away.

Testing and check-ups: Your healthcare professional may do blood tests before you start RIVA-SIMVASTATIN and regularly during your treatment. These tests will check:

  • the amount of cholesterol and other fats in your blood,
  • your liver function.

Depending on your test results, your healthcare professional may adjust your dose, temporarily stop, or discontinue your treatment with RIVA-SIMVASTATIN.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

Serious Drug Interactions

Do not use RIVA-SIMVASTATIN if you are taking any of the following:

  • certain antifungal medicines (itraconazole, ketoconazole, posaconazole, or voriconazole),
  • certain medicines used to treat HIV (nelfinavir, ritonavir, or saquinavir),
  • certain medicines used to treat hepatitis C virus (boceprevir or telaprevir),
  • certain antibiotics (erythromycin, clarithromycin, or telithromycin),
  • medicines containing cobicistat,
  • nefazodone, used to treat depression,
  • gemfibrozil, used for lowering cholesterol,
  • cyclosporine, used to prevent organ transplant rejection,
  • danazol, used to treat endometriosis or fibrocystic breast disease.

Taking RIVA-SIMVASTATIN with any of these medications may cause a serious drug interaction. Ask your healthcare professional if you are unsure.

The following may interact with RIVA-SIMVASTATIN:

  • Fibrates, used to lower fat levels in the blood (such as fenofibrate or bezafibrate)
  • Amiodarone, used to treat an irregular heartbeat
  • Verapamil, diltiazem, or amlodipine, used to treat high blood pressure, angina, or other heart conditions
  • Lomitapide, used to treat a serious and rare genetic cholesterol condition
  • Niacin
  • Daptomycin, used to treat complicated skin and bacterial infections in the blood
  • Colchicine, used for gout
  • Cholestyramine, used to lower cholesterol
  • Anticoagulants, medications that prevent blood clots, such as warfarin or coumarin
  • Digoxin, used to treat heart problems
  • Avoid drinking grapefruit juice while taking RIVA-SIMVASTATIN.

How to take RIVA-SIMVASTATIN:

  • Take RIVA-SIMVASTATIN exactly as your healthcare professional tells you to.
  • It is recommended to take RIVA-SIMVASTATIN in the evening, with a meal.

  • Carefully follow any measures that your healthcare professional has recommended for diet, exercise or weight control.
  • When taking RIVA-SIMVASTATIN, avoid consuming grapefruit juice.
  • Keep regular appointments with your healthcare professional so that your blood can be tested and your progress checked at proper intervals.

Usual dose:

The dose of RIVA-SIMVASTATIN prescribed to you depends on your condition and/or your blood cholesterol level. Your healthcare professional may change your dose depending on your response to RIVA-SIMVASTATIN.

  • For adults, the usual dosage is 5 mg to 40 mg once a day in the evening. • For children (10 to less than 18 years old), the usual dosage is 10 mg to 40 mg once a day in the evening. The maximum recommended dose is 40 mg a day.

Overdose:

If you think you, or a person you are caring for, have taken too much RIVA-SIMVASTATIN, contact a healthcare professional, hospital emergency department, regional poison control centre or Health Canada’s toll-free number, 1-844 POISON-X (1-844-764-7669) immediately, even if there are no signs or symptoms.

Missed dose:

If you miss taking a tablet at its usual time, take it as soon as possible. However, if it is too close to the time of your next dose, skip the missed dose and take your next dose as scheduled. Do not take a double dose.

What are the possible side effects from using RIVA-SIMVASTATIN?

These are not all the possible side effects you may have when taking RIVA-SIMVASTATIN. If you experience any side effects not listed here, tell your healthcare professional.

  • Persistent cough and/or shortness of breath
  • Erectile dysfunction
  • Acid reflux
  • Constipation
  • Diarrhea
  • Gas
  • Nausea
  • Abdominal pain or discomfort
  • Vomiting
  • Confusion
  • Dizziness
  • Headache
  • Memory loss
  • Poor memory
  • Hair loss
  • Itchy skin
  • Rash on the skin or inside the mouth (Lichen rash)
  • Trouble sleeping
  • Weakness

Serious side effects and what to do about them

Frequency/Side Effect/Symptom

Talk to your healthcare professional

Stop taking this drug and get immediate medical help

Only if severe In all cases

RARE

Allergic Reaction: difficulty swallowing or breathing, wheezing, drop in blood pressure, feeling sick to your stomach and throwing up, hives or rash, swelling of the face, lips, tongue or throat

  • Serious side effects and what to do about them

Frequency/Side Effect/Symptom

Talk to your healthcare professional

Stop taking this drug and get immediate medical help

Only if severe In all cases

Liver Disorder: yellowing of the skin or eyes, dark urine and pale stools, abdominal pain, nausea, vomiting, loss of appetite

✓

Muscle Disorders:

Myopathy (muscle pain): aching muscles, tenderness or weakness that you cannot explain

Rhabdomyolysis (breakdown of damaged muscle): muscle tenderness, weakness, red-brown (tea-coloured) urine

These muscle disorders can be accompanied with fever or feeling unwell.

✓

Myasthenia Gravis (muscle weakness):

General: difficulty in speaking, chewing, and swallowing or weakness of arms and legs and in some cases, muscles used when breathing

Ocular (eye): weak, drooping eyelid(s) causing vision changes

✓

UNKNOWN

Blood Disorders:

Anaemia (decreased number of red blood cells): fatigue, loss of energy, irregular heartbeats, pale complexion, shortness of breath, weakness

Leukopenia (decreased white blood cells): infections, fatigue, fever, aches, pains and flu-like symptoms

Thrombocytopenia (low blood platelets): bruising or bleeding for longer than usual if you hurt yourself, fatigue and weakness

✓

Depression (sad mood that won’t go away): difficulty sleeping or sleeping too much, changes in appetite or weight, feelings of worthlessness, guilt, regret, helplessness or hopelessness, withdrawal from social situations, family, gatherings and activities with friends, reduced libido (sex drive) and thoughts of death or suicide. If you have a history of depression, your depression may become worse.

✓

Hyperglycemia (high blood sugar): increased thirst, frequent urination, dry skin, headache, blurred vision and fatigue

  • Serious side effects and what to do about them

Frequency/Side Effect/Symptom

Talk to your healthcare professional

Stop taking this drug and get immediate medical help

Only if severe In all cases

Interstitial lung disease

(disease that inflames or scars lung tissue): shortness of breath when at rest that gets worse with exertion, dry cough

✓

Pancreatitis (inflammation of the pancreas): upper abdominal pain, fever, rapid heartbeat, nausea, vomiting, tenderness when touching the abdomen

✓

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your healthcare professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Store your tablets at room temperature (15°C – 30°C), in the original package, away from heat and direct light, and out of damp places, such as the bathroom or kitchen.

Keep all medicines out of the reach and sight of children.

If you want more information about RIVA-SIMVASTATIN:

  • Talk to your healthcare professional.
  • Find the full Product Monograph that is prepared for healthcare professionals and includes the Patient Medication Information by visiting the Health Canada Drug Product Database website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website www.labriva.com; or by calling 1-800-363-7988.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02566818

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Riva-Simvastatin (Laboratoire Riva, PM 00083947)

Rx or OTC
Prescription (Rx)?
DIN 02566818, 02566826, 02566834, 02566842, 02566850
Schedule(s) PRESCRIPTION
Active ingredient(s) Simvastatin
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C10 Lipid modifying agents
      1. C10A Lipid modifying agents, plain
        1. C10AA HMG CoA reductase inhibitors, plain lipid modifying drugs
          1. C10AA01 Simvastatin
Company LABORATOIRE RIVA INC.
Current status Approved
Current status date March 20, 2026
Strengths and forms
DIN Strength Dosage form(s) Current status
02566818 5 MG Tablet Approved March 20, 2026
02566826 10 MG Tablet Approved March 20, 2026
02566834 20 MG Tablet Approved March 20, 2026
02566842 40 MG Tablet Approved March 20, 2026
02566850 80 MG Tablet Approved March 20, 2026

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.